Test Price
2,800 AED✅ Home Collection Available
CCDC28B Gene Bardet‑Biedl Syndrome Modifier NGS Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Data Privacy: Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient consent and safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
The CCDC28B modifier gene is a critical locus in Bardet‑Biedl syndrome (BBS) – a multi‑systemic ciliopathy. This next‑generation sequencing (NGS) genetic test provides a definitive molecular diagnosis for patients with hepatology, nephrology, and endocrinology‑related manifestations, establishing inherited risk and guiding personalized care. The test screens the entire coding sequence and flanking intronic regions using validated NGS platforms.
| Feature | Our CCDC28B NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene, all exons & splicing sites | Single‑fragment, limited coverage |
| Methodology | NGS (LC‑MS/MS verified) | Sanger (capillary electrophoresis) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Consent & Counselling | Included (genetic pedigree charting) | Often separate |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that the CCDC28B NGS test offers high sensitivity for modifier variants in Bardet‑Biedl syndrome. However, results must be interpreted alongside full clinical evaluation, detailed family history, and specialist assessment. Pre‑ and post‑test genetic counseling is mandatory for informed decision‑making and accurate risk stratification.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results are not a substitute for ongoing medical care.
Exclusion Criteria & Emergency Red Flags
- Not for acute emergency diagnostics; genetic results do not replace urgent care.
- Minors cannot be tested without a legal guardian’s explicit, documented consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients on full‑dose anticoagulants – special phlebotomy precautions required (alternative FTA card collection available).
- ER Red Flags: sudden vision loss, acute renal failure, severe hyperglycaemia, or new‑onset seizures — go directly to the nearest hospital.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the CCDC28B NGS test for Bardet‑Biedl syndrome?
This NGS test demonstrates 99.9% diagnostic sensitivity for known pathogenic variants in the CCDC28B gene, validated according to international clinical datasets and external quality assessment. It screens the entire coding sequence and flanking intronic regions, minimizing false‑negative results.
2. How is the sample collected and what is the pre‑test preparation?
A simple blood draw (whole blood), one drop on an FTA card, or extracted DNA is accepted by our VIP mobile phlebotomy team. Pre‑test includes a mandatory genetic counseling session to chart a pedigree of affected family members and document clinical history before testing.
3. Which medical specialists should order this test and interpret the results?
The test is ideally requested by a Clinical Geneticist, Pediatric Endocrinologist, or Nephrologist, working with a multi‑disciplinary team. General physicians may facilitate initial screening, but definitive interpretation and post‑counseling require specialist input in line with DHA guidelines.
UAE Regulatory & Data Privacy Adherence
Our laboratory fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is stored securely, accessed only by authorized personnel, and used exclusively for diagnostic purposes. For data subject requests or privacy concerns, contact our Data Protection Officer via the laboratory’s official communication channels.
Clinical & Logistical Metadata
| Test Name | CCDC28B Gene Bardet‑Biedl Syndrome Modifier NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (peripheral), FTA Card, or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – LC‑MS/MS verified |
| ICD-10-CM Code | Q87.89, Z13.79, Z14.8 |
| LOINC Code | 99058-9 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians